Andrea Schnatz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrea Schnatz has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Christina Francisca Vogelaar
Department of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (Rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
2 shared publications Ari Waisman
Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, 55131, Germany
1 shared publication- Cedric S. Raine
Robyn Klein (St. Louis, MO, USA
1 shared publication Christina Müller
Institute of Developmental Biology and Neurobiology, Section Cellular Neurobiology, Johannes Gutenberg University Mainz, Mainz, 55099, Germany
1 shared publication- Frauke Zipp
Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
1 shared publication Ilse von Graevenitz
Institute for Microanatomy and Neurobiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, 55131, Germany
1 shared publication
Latest Publications
A predominantly glial origin of axonal ribosomes after nerve injury
Axonal mRNA transport and local protein synthesis are crucial for peripheral axon regeneration. To date, it remains unclear how ribosomes localize to axons. They may be co‐transported with mRNAs or, as suggested by recent studies, transferred from Schwann cells (SC). Here, we generated transgenic “RiboTracker” mice expressing tdTomato‐tagged ribosomal protein L4 in specific cell types when crossed with Cre lines. Two neuronal RiboTracker‐Cre lines displayed extremely low levels of axonal L4‐tdTomato‐positive ribosomes. In contrast, two glial RiboTracker‐Cre lines revealed tagged ribosomes in sciatic nerve (SN) axons with increasing amounts after injury. Furthermore, non‐RiboTracker dorsal root ganglia co‐cultured with L4‐tdTomato‐expressing SCs displayed tagged ribosomes in axons. These data provide unequivocal evidence that SN axons receive ribosomes from SCs upon injury and indicate that glial cells are the main source of axonal ribosomes.
A predominantly glial origin of axonal ribosomes after nerve injury
Axonal mRNA transport and local protein synthesis are crucial for peripheral axon regeneration. To date, it remains unclear how ribosomes localize to axons. They may be co‐transported with mRNAs or, as suggested by recent studies, transferred from Schwann cells (SC). Here, we generated transgenic “RiboTracker” mice expressing tdTomato‐tagged ribosomal protein L4 in specific cell types when crossed with Cre lines. Two neuronal RiboTracker‐Cre lines displayed extremely low levels of axonal L4‐tdTomato‐positive ribosomes. In contrast, two glial RiboTracker‐Cre lines revealed tagged ribosomes in sciatic nerve (SN) axons with increasing amounts after injury. Furthermore, non‐RiboTracker dorsal root ganglia co‐cultured with L4‐tdTomato‐expressing SCs displayed tagged ribosomes in axons. These data provide unequivocal evidence that SN axons receive ribosomes from SCs upon injury and indicate that glial cells are the main source of axonal ribosomes.
- 28 February 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (430)
Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation
Targeting neuronal interleukin-4 signaling is beneficial for clinical progression and axon pathology in different neuroinflammation models.
- 28 February 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (430)
Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation
Targeting neuronal interleukin-4 signaling is beneficial for clinical progression and axon pathology in different neuroinflammation models.